Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-03

Clinical Trial Update: Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

View source ↗

Summary

A Pfizer-sponsored trial evaluated quality of life in Alzheimer's disease patients treated with Aricept; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aricept (Donepezil)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer Disease | Status: COMPLETED | Results posted: 2010-08-03